BioNexus Gene Lab (BGLC) Long-Term Debt Issuances (2019 - 2025)
BioNexus Gene Lab recorded quarterly Long-Term Debt Issuances of $15528.0 in Q1 2025, down 24.06% quarter-over-quarter from $20448.0 in Q1 2024, and down 24.06% year-over-year from $20448.0 in Q1 2024.
BioNexus Gene Lab's Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at $15528.0 for Q1 2025.
- In Q1 2025, Long-Term Debt Issuances fell 24.06% year-over-year to $15528.0; the TTM figure through Mar 2025 stood at $29979.0 (up 291.63% YoY), while the FY2024 annual figure was $78835.0, down 94.42% from the prior year.
- Long-Term Debt Issuances came in at $15528.0 for Q1 2025 at BioNexus Gene Lab, down from $20448.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $20448.0 in Q1 2024 to a low of -$8550.0 in Q1 2021.
- A 3-year average of $2926.6 and a median of -$5997.0 in 2021 frame the typical range for Long-Term Debt Issuances.
- Across the five-year window, Long-Term Debt Issuances sank 418.99% in 2021 and dropped 24.06% in 2025, its largest moves.
- BioNexus Gene Lab's Long-Term Debt Issuances stood at -$5997.0 in 2021, then jumped by 440.97% to $20448.0 in 2024, then decreased by 24.06% to $15528.0 in 2025.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $15528.0, $20448.0, and -$5997.0 for Q1 2025, Q1 2024, and Q3 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 58.00 Mn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | - |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 26.60 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 415.00 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | - |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | - |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 18.40 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | - |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 15,528.00 |
| Mar 31, 2025 | 15,528.00 |
| Mar 31, 2024 | 20,448.00 |
| Mar 31, 2024 | 20,448.00 |
| Sep 30, 2021 | -5,997.00 |
| Sep 30, 2021 | -5,997.00 |
| Jun 30, 2021 | -6,796.00 |
| Jun 30, 2021 | -6,796.00 |
| Mar 31, 2021 | -8,550.00 |
| Mar 31, 2021 | -8,550.00 |
| Sep 30, 2020 | 1,880.00 |
| Sep 30, 2020 | 1,880.00 |
| Jun 30, 2020 | -2,612.00 |
| Jun 30, 2020 | -2,612.00 |
| Mar 31, 2020 | -6,399.00 |
| Mar 31, 2020 | -6,399.00 |
| Sep 30, 2019 | -5,534.00 |
| Sep 30, 2019 | -5,534.00 |